Skip to content

To see how homoeopathic medicine helps in control high blood pressure.

Efficacy of individualized homoeopathic remedies in management of essential hypertension by using modified naranjo criteria : An experimental study - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101895
Enrollment
40
Registered
2026-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Homoeopathic Management: Individualized homoeopathic medicine 4 globules per dose potency as per Individual case frequency as per susceptibility of individual case route of administrat

Sponsors

Dr.Nikhil Namdev Kumbhar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically diagnosed cases of essential hypertension Newly diagnosed cases without any antihypertensive Age group 18-65 years Both sexes

Exclusion criteria

Exclusion criteria: Malignant hypertension and secondary hypertension Patient with isolated hypertension Patient who were pregnant breastfeeding Cases diagnosed with developmental defect or congenital abnormalities Patient with history of drugs,alcohol abuse,chronic smoker Continued antihypertensive therapy was administered for a minimum 6 months

Design outcomes

Primary

MeasureTime frame
Outcome assessment will be done by applying Modified Narnjo criteria for homoeopathy Timepoint: Outcome assessment will be done by Baseline-0 Midstudy-1.5 months( 3rd follow up) Post study -3 months (6th follow up)

Secondary

MeasureTime frame
Not applicableTimepoint: Not applicable

Countries

India

Contacts

Public ContactDrNikhil Namdev Kumbhar

Dr. J J Magdum Homoeopathic Medical College , Jaysingpur

pawarpadmashree1@gmail.com9975377151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026